Placeholder

Contents

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

Product Description

In Every Issue

3    Letter from the Editor

8    Upfront
A brief review of industry news at press time

36    Pharma Trax
Sales, marketing, and R&D trends from industry analysts

40    What’s New
New healthcare-related products, services, and companies

42    E-Media
New electronic and Web-based applications, sites, and technologies

45    On the Calendar
Industry events

46    Talent Pool
Executive appointments and promotions

50    Last Word
Ignite Health’s Fabio Gratton recaps social media hearings.

On The Cover
12    Incentive Compensation
Sales models are evolving to meet the new ­challenges of today’s market, and incentive ­compensation and ­measurement plans are changing as a result.

FEATURES
20    Name That Brand: A Pilot Program
Taking an active role in the PDUFA pilot ­naming evaluation program will be costly for the industry.

24    Pharmaceutical Manufacturing Under Scrutiny
Regulators are increasing their presence on the line to ensure GMP is top of mind for companies.
28    Dr. Thomas Steitz: The Right Chemistry
Dr. Steitz, Nobel Prize Winner and Co-Founder of Rib-X, is advancing the discovery of new antibiotics that have the potential to save lives.

SHOWCASE FEATURE
32    Executive Coaching
Companies that support executive coaching experience improvements in productivity, quality, organizational strength, customer service, and
shareholder value.

Only in the Digital Edition of the January 2010 issue of PharmaVOICE

Incentive Compensation
Aligning Compensation Plans with Newer Sales Models and Metrics
Evolving Compensation Models

Name That Brand: A Pilot Program
FDA Sheds Light on Pilot Program

Pharmaceutical Manufacturing Under Scrutiny

Quality a Global Issue
The Top Observations from Manufacturing Inspections
Genzyme Corp. Responds

The Right Chemistry — Dr. Thomas Steitz, Nobel Prize Winner

A Breakthrough Phase

Partners in Public Health
Industry experts discuss the role of pharmaceutical companies in pandemic preparedness.

ON THE COVER
Incentive Compensation
Sales models are evolving to meet the new ­challenges of today’s market, and incentive ­compensation and ­measurement plans are changing as a result.

Aligning Compensation Plans with Newer Sales Models and Metrics
Evolving Compensation Models
Cutting Edge’s Fair-Market Value Report Series

FEATURE ARTICLES
Name That Brand: A Pilot Program
Taking an active role in the PDUFA pilot ­naming evaluation program will be costly for the industry.
FDA Sheds Light on Pilot Program

Pharmaceutical Manufacturing Under Scrutiny
The FDA’s heightened focus on safety has reached the manufacturing level. Regulators are increasing their presence on the line to ensure GMP is top of mind for companies.

Quality a Global Issue
The top observations from manufacturing inspections from 2000 through Nov. 29, 2009.
Genzyme Corp. Responds

INDUSTRY BIO
The Right Chemistry: Dr. Thomas Steitz, Nobel Prize Winner
Dr. Thomas Steitz has not only made a key contribution to understanding the ­function of life’s protein-making factory, but in co-founding Rib-X he also has played a significant role in advancing the discovery of new antibiotics that have the potential to save lives.

A Breakthrough Phase
Academic Greatness
The Nobel Prize Award Ceremony 2009

EXCLUSIVE DIGITAL ARTICLE
Partners in Public Health
Industry experts discuss the role of pharmaceutical companies in pandemic preparedness.

IN EVERY ISSUE 
Pharma Trax
Trends from industry analysts

Talent Pool
More industry appointments

On the Calendar
More industry events and conferences

Last Word
A Passion for Social Media
Ignite Health’s Presentation to the FDA

 

FEEDBACK